Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (ANIX) Actualités

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ANIX

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/11/2024	14h15	PR Newswire (US)	Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset	NASDAQ:ANIX	Anixa Biosciences Inc
18/11/2024	14h20	PR Newswire (US)	Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
08/11/2024	19h31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANIX	Anixa Biosciences Inc
08/11/2024	19h17	PR Newswire (US)	Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
06/11/2024	14h30	PR Newswire (US)	Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
31/10/2024	13h15	PR Newswire (US)	Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024	NASDAQ:ANIX	Anixa Biosciences Inc
28/10/2024	13h30	PR Newswire (US)	Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
23/10/2024	17h27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANIX	Anixa Biosciences Inc
15/10/2024	15h00	PR Newswire (US)	Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
07/10/2024	14h30	PR Newswire (US)	Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development	NASDAQ:ANIX	Anixa Biosciences Inc
30/09/2024	14h30	PR Newswire (US)	Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial	NASDAQ:ANIX	Anixa Biosciences Inc
24/09/2024	14h30	PR Newswire (US)	Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine	NASDAQ:ANIX	Anixa Biosciences Inc
18/09/2024	14h30	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference	NASDAQ:ANIX	Anixa Biosciences Inc
06/09/2024	23h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANIX	Anixa Biosciences Inc
03/09/2024	14h30	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium	NASDAQ:ANIX	Anixa Biosciences Inc
26/08/2024	14h30	PR Newswire (US)	Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ANIX	Anixa Biosciences Inc
29/07/2024	14h45	PR Newswire (US)	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting	NASDAQ:ANIX	Anixa Biosciences Inc
23/07/2024	14h15	PR Newswire (US)	Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy	NASDAQ:ANIX	Anixa Biosciences Inc
17/07/2024	14h00	PR Newswire (US)	Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology	NASDAQ:ANIX	Anixa Biosciences Inc
15/07/2024	14h30	PR Newswire (US)	Anixa Biosciences Announces $5 Million Share Repurchase Program	NASDAQ:ANIX	Anixa Biosciences Inc
24/06/2024	14h45	PR Newswire (US)	Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
21/05/2024	13h30	PR Newswire (US)	Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
08/05/2024	14h25	PR Newswire (US)	Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines	NASDAQ:ANIX	Anixa Biosciences Inc
06/05/2024	14h05	PR Newswire (US)	Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja	NASDAQ:ANIX	Anixa Biosciences Inc
30/04/2024	13h45	PR Newswire (US)	Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024	NASDAQ:ANIX	Anixa Biosciences Inc
18/04/2024	14h20	PR Newswire (US)	Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board	NASDAQ:ANIX	Anixa Biosciences Inc
14/03/2024	13h45	PR Newswire (US)	Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties	NASDAQ:ANIX	Anixa Biosciences Inc
11/03/2024	13h00	PR Newswire (US)	Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress	NASDAQ:ANIX	Anixa Biosciences Inc
12/02/2024	13h30	PR Newswire (US)	Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial	NASDAQ:ANIX	Anixa Biosciences Inc
08/02/2024	22h15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ANIX	Anixa Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:ANIX

1 2 3 4 5 6 7 8 Suivant >>

Credit Agricole

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales